Celgene Reports Third Quarter 2017 Operating and Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Celgene (CELG) PT Lowered to $125 at Jefferies; Reiterates Buy
October 27, 2017 8:40 AM EDTJefferies lowered its price target on Celgene (NASDAQ: CELG) to $125.00 (from $160.00) while maintaining a Buy rating.
While clearly a disappointment and large market reaction, moving forward the question is what could turn this around. Analyst Michael Yee thinks at $95 (close to $80-85 no pipeline value), it's overdone in bigger picture.
... MoreCelgene (CELG) Tops Q3 EPS by 4c, Sales Miss; Raises Low End of FY EPS Guidance, Offers 2020 Targets
October 26, 2017 7:34 AM EDTCelgene (NASDAQ: CELG) reported Q3 EPS of $1.91, $0.04 better than the analyst estimate of $1.87. Revenue for the quarter came in at $3.29 billion versus the consensus estimate of $3.42 billion.
GUIDANCE:
Celgene sees FY2017 EPS of $7.30-$7.35, versus the consensus of... More
